Melody Cobleigh - Researcher Profile

Publications

2 shown

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

Charles L. Vogel , Melody Cobleigh , Debu Tripathy +10 more

Single-agent trastuzumab is active and well tolerated as first-line treatment of women with metastatic breast cancer with HER2 3+ overexpression by IHC or gene amplification by ...

2002 Journal of Clinical Oncology 2948 citations

Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

Melody Cobleigh , Charles L. Vogel , Debu Tripathy +8 more

PURPOSE: Overexpression of the HER2 protein occurs in 25% to 30% of human breast cancers and leads to a particularly aggressive form of the disease. Efficacy and safety of recom...

1999 Journal of Clinical Oncology 2778 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 5,726
Institution: Kaiser Permanente

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-6385-4693

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.